Publications by authors named "Armstrong Ndihokubwayo"

We describe cases with monkeypox virus (MPXV) Clade Ib in Burundi from their first detection in July until 20 August 2024. Testing 442 people with vesicular lesions confirmed 170 cases (98 male; 72 female), 82 (48%) being < 15 years old. Differential diagnosis of the first 30 individuals testing MPXV negative revealed chickenpox in 20.

View Article and Find Full Text PDF

Background: The emergence and rapid spread of new severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) variants have challenged the control of the COVID-19 pandemic globally. Burundi was not spared by that pandemic, but the genetic diversity, evolution, and epidemiology of those variants in the country remained poorly understood. The present study sought to investigate the role of different SARS-COV-2 variants in the successive COVID-19 waves experienced in Burundi and the impact of their evolution on the course of that pandemic.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Armstrong Ndihokubwayo"

  • - Armstrong Ndihokubwayo's recent research primarily focuses on the epidemiology and genetic surveillance of infectious diseases in Burundi, particularly concerning monkeypox and SARS-CoV-2.
  • - In his study on monkeypox, he reported the first findings of MPXV Clade Ib in Burundi, confirming 170 cases from a sample of 442 individuals with vesicular lesions, highlighting a significant incidence among children under 15.
  • - His genomic surveillance of SARS-CoV-2 analyzed the emergence and evolution of different variants during the COVID-19 pandemic in Burundi, aiming to provide insights into their impact on the infection waves experienced in the region.